0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.52%
Positive revenue growth while 0464.HK is negative. John Neff might see a notable competitive edge here.
16.18%
Gross profit growth at 50-75% of 0464.HK's 27.23%. Martin Whitman would question if cost structure or brand is lagging.
No Data
No Data available this quarter, please select a different quarter.
59.72%
Operating income growth above 1.5x 0464.HK's 0.21%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
1154.17%
Net income growth above 1.5x 0464.HK's 75.42%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
1100.00%
EPS growth above 1.5x 0464.HK's 75.58%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
1100.00%
Diluted EPS growth above 1.5x 0464.HK's 75.58%. David Dodd would see if there's a robust moat protecting these shareholder gains.
3.74%
Share count expansion well above 0464.HK's 0.47%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
3.76%
Diluted share count expanding well above 0464.HK's 0.46%. Michael Burry would fear significant dilution to existing owners' stakes.
2215.96%
Dividend growth of 2215.96% while 0464.HK is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-178.65%
Negative OCF growth while 0464.HK is at 273.62%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-180.23%
Negative FCF growth while 0464.HK is at 329.30%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-3.04%
Negative 10Y revenue/share CAGR while 0464.HK stands at 0.85%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
23.10%
Positive 5Y CAGR while 0464.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-2.31%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-979.39%
Negative 10Y OCF/share CAGR while 0464.HK stands at 282.61%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-234.22%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
42.96%
3Y OCF/share CAGR under 50% of 0464.HK's 189.40%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-37.41%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-46.65%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
6.63%
Positive short-term CAGR while 0464.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
28.42%
Positive 5Y equity/share CAGR while 0464.HK is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
10.30%
Positive short-term equity growth while 0464.HK is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
-64.73%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-43.17%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-100.00%
Firm’s AR is declining while 0464.HK shows 26.20%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-4.99%
Inventory is declining while 0464.HK stands at 6.80%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-4.21%
Negative asset growth while 0464.HK invests at 3.78%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.59%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-16.02%
We’re deleveraging while 0464.HK stands at 1.84%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while 0464.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-14.33%
We cut SG&A while 0464.HK invests at 22.04%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.